BioCryst

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.

About BCRX

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.

CEO

Jon P. Stonehouse

CEOJon P. Stonehouse

Employees

536

Employees536

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

1986

Founded1986

Employees

536

Employees536

BCRX Key Statistics

Market cap

915.31M

Market cap915.31M

Price-Earnings ratio

-3.76

Price-Earnings ratio-3.76

Dividend yield

—

Dividend yield—

Average volume

3.05M

Average volume3.05M

High today

$4.59

High today$4.59

Low today

$4.27

Low today$4.27

Open price

$4.50

Open price$4.50

Volume

4.69M

Volume4.69M

52 Week high

$9.07

52 Week high$9.07

52 Week low

$4.27

52 Week low$4.27

BCRX News

TipRanks 3d

BioCryst announces Brazilian Health Regulatory Agency approval for Orladeyo

BioCryst announced that the Brazilian Health Regulatory Agency, or ANVISA, has granted approval for oral, once-daily Orladeyo for the prophylaxis of hereditary...

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

16.7%

Sell